BioCentury
ARTICLE | Company News

Evotec, British Biotech medicinal chemistry deal

November 7, 2002 8:00 AM UTC

Evotec (NMarkt:EVT) will apply lead optimization and medicinal chemistry to make peptide deformylase (PDF) inhibitors for British Biotech (LSE:BBG; BBIOY) to screen for anti-infective therapeutic lead...